AU9064991A - Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy - Google Patents

Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy

Info

Publication number
AU9064991A
AU9064991A AU90649/91A AU9064991A AU9064991A AU 9064991 A AU9064991 A AU 9064991A AU 90649/91 A AU90649/91 A AU 90649/91A AU 9064991 A AU9064991 A AU 9064991A AU 9064991 A AU9064991 A AU 9064991A
Authority
AU
Australia
Prior art keywords
angiotensin
treatment
receptor antagonists
diabetic retinopathy
retinopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90649/91A
Inventor
James Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU9064991A publication Critical patent/AU9064991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU90649/91A 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy Abandoned AU9064991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9027211 1990-12-14
GB909027211A GB9027211D0 (en) 1990-12-14 1990-12-14 Medicaments

Publications (1)

Publication Number Publication Date
AU9064991A true AU9064991A (en) 1992-07-08

Family

ID=10687045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90649/91A Abandoned AU9064991A (en) 1990-12-14 1991-12-12 Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy

Country Status (5)

Country Link
EP (1) EP0561901A1 (en)
JP (1) JPH06503335A (en)
AU (1) AU9064991A (en)
GB (1) GB9027211D0 (en)
WO (1) WO1992010183A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB9208116D0 (en) 1992-04-13 1992-05-27 Ici Plc Therapeutic agents
NZ251741A (en) * 1992-04-13 1997-06-24 Zeneca Ltd Use of angiotensin ii antagonists for treating disease conditions associated with impaired neuronal conduction velocity
AU1423795A (en) * 1994-02-08 1995-08-29 Novartis Ag Treatment of normotensive glaucoma with angiotensin ii antagonists
US5658734A (en) * 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
WO2000010605A2 (en) * 1998-08-20 2000-03-02 Senju Pharmaceutical Co., Ltd. Preventives or remedies for eye circulatory failure
DK1197223T3 (en) * 1999-04-28 2005-05-30 Takeda Pharmaceutical Pharmaceutical preparation for the prevention, treatment or developmental inhibition of simple retinopathy or preproliferative retinopathy
US6800439B1 (en) 2000-01-06 2004-10-05 Affymetrix, Inc. Methods for improved array preparation
US6806361B1 (en) 2000-03-17 2004-10-19 Affymetrix, Inc. Methods of enhancing functional performance of nucleic acid arrays
US6833450B1 (en) 2000-03-17 2004-12-21 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
US7005259B1 (en) 2000-06-01 2006-02-28 Affymetrix, Inc. Methods for array preparation using substrate rotation
US6380377B1 (en) * 2000-07-14 2002-04-30 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US6596490B2 (en) 2000-07-14 2003-07-22 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
EP1752450A1 (en) * 2005-08-01 2007-02-14 Merck Sante Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
SG52330A1 (en) * 1989-06-14 1998-09-28 Smithkline Beecham Corp Imidazolyl-alkenoic acids
US5294631A (en) 1990-04-13 1994-03-15 Smithkline Beecham Corporation Substituted benzimidazoles useful as angiotension II receptor antagonists

Also Published As

Publication number Publication date
JPH06503335A (en) 1994-04-14
GB9027211D0 (en) 1991-02-06
EP0561901A1 (en) 1993-09-29
WO1992010183A1 (en) 1992-06-25

Similar Documents

Publication Publication Date Title
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
AU9058591A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
AU649605B2 (en) Retinal, derivatives and their therapeutic use
AU4673393A (en) Use of 3-phenoxypyridine in the treatment of psychomotor stimulant addiction
HK1005801A1 (en) N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
EP0412594A3 (en) Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin ii antagonists
AU9069191A (en) Use of angiotensin ii receptor antagonists in the prevention of restinosis
AU9065291A (en) Use of angiotensin ii receptor antagonists in the treatment of macular degeneration
HK1001286A1 (en) Benzopyrans and their use as therapeutic agents.
AU9084191A (en) Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke
EP0547178A4 (en) Novel cholecystokinin antagonists, their preparation and therapeutic use
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
AU4163693A (en) Angiotension II receptor antagonists for the treatment of disturbances in cardiac rhythm
AU4163793A (en) Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
AU9064191A (en) Use of angiotensin ii receptor antagonists in the treatment of atheroma
AU9081691A (en) Use of angiotensin ii antagonists in the treatment of angina pectoris
GB9601844D0 (en) Improvements in or relating to the detection of variations in human histamine H� receptors
AU9069291A (en) Use of angiotensin ii receptor antagonists for the preparation of a medicament for improving cognitive function
AU9071291A (en) Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
ZA902245B (en) Azolylethylcyclopropanes,the preparation thereof and the use thereof as crop protection agents
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU6901191A (en) Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
AU2641288A (en) Methods and compositions for activating the human insulin receptor kinase